A clinical-stage biopharmaceutical company has acquired the rights to a drug that UB scientists have begun developing for Duchenne muscular dystrophy, a common, fatal genetic disease affecting young boys.
UB faculty member Kathryn Bryk Friedman has been appointed to a prominent SUNY fellowship program designed to foster research collaborations across the state campus system.
An oral biologic medication has successfully treated chronic, precancerous inflammation in the intestine, according to results of an animal study authored by a UB MD/PhD student.
Out of nearly 100 concepts from faculty across the university, 14 multidisciplinary teams are preparing to submit preliminary proposals for the next phase of the selection process for UB’s Communities of Excellence.
The $765 million class action settlement of concussion claims for retired NFL players is a “potential template” for other professional athletes, according to UB Law School faculty member Christine P. Bartholomew,
It is not only prenatal drug exposure, but also conditions related to drug use that can influence negative behavior in children, according to a new study from UB’s Research Institute on Addictions.
The Society of International Economic Law conference held in July in Bern, Switzerland, and co-chaired by UB faculty member Meredith Kolsky Lewis, was a truly global gathering.
Patients with chronic obstructive pulmonary disease (COPD) report improved symptoms and health status when they use a hand-held respiratory device called the Lung Flute®, according to a new UB study.
The New York State Department of Health has extended its contract with UB biostatistician Randolph L. Carter to fund his evaluation of the state’s Early Intervention Program for young children through 2016.
Carl Lund, SUNY Distinguished Teaching Professor in the Department of Chemical and Biological Engineering, has been named a fellow of the American Institute of Chemical Engineers.
